Delayed
Japan Exchange
10:27:48 2024-06-12 pm EDT
|
5-day change
|
1st Jan Change
|
2,798
JPY
|
-1.24%
|
|
-1.62%
|
+5.43%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
57,811
|
42,166
|
39,399
|
65,143
|
52,791
|
49,202
|
Enterprise Value (EV)
1 |
64,324
|
44,862
|
35,712
|
50,318
|
36,751
|
30,301
|
P/E ratio
|
14.9
x
|
20.9
x
|
10.4
x
|
9.17
x
|
10.9
x
|
11.8
x
|
Yield
|
1.78%
|
2.43%
|
2.55%
|
1.54%
|
2.11%
|
2.27%
|
Capitalization / Revenue
|
0.22
x
|
0.16
x
|
0.15
x
|
0.23
x
|
0.19
x
|
0.17
x
|
EV / Revenue
|
0.24
x
|
0.17
x
|
0.13
x
|
0.18
x
|
0.13
x
|
0.11
x
|
EV / EBITDA
|
6.73
x
|
5.05
x
|
3.51
x
|
3.36
x
|
3.05
x
|
2.78
x
|
EV / FCF
|
61.8
x
|
18.3
x
|
5.02
x
|
4.46
x
|
80.3
x
|
9.58
x
|
FCF Yield
|
1.62%
|
5.45%
|
19.9%
|
22.4%
|
1.24%
|
10.4%
|
Price to Book
|
0.63
x
|
0.45
x
|
0.42
x
|
0.65
x
|
0.5
x
|
0.46
x
|
Nbr of stocks (in thousands)
|
22,805
|
22,805
|
22,297
|
22,309
|
22,322
|
22,334
|
Reference price
2 |
2,535
|
1,849
|
1,767
|
2,920
|
2,365
|
2,203
|
Announcement Date
|
6/13/18
|
6/12/19
|
6/12/20
|
6/11/21
|
6/15/22
|
6/15/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
268,205
|
264,926
|
270,313
|
284,492
|
279,462
|
281,871
|
EBITDA
1 |
9,559
|
8,888
|
10,180
|
14,961
|
12,069
|
10,903
|
EBIT
1 |
4,414
|
3,743
|
5,593
|
10,488
|
7,645
|
6,553
|
Operating Margin
|
1.65%
|
1.41%
|
2.07%
|
3.69%
|
2.74%
|
2.32%
|
Earnings before Tax (EBT)
1 |
5,787
|
3,833
|
5,781
|
10,636
|
7,687
|
6,571
|
Net income
1 |
3,869
|
2,016
|
3,822
|
7,109
|
4,830
|
4,177
|
Net margin
|
1.44%
|
0.76%
|
1.41%
|
2.5%
|
1.73%
|
1.48%
|
EPS
2 |
169.7
|
88.38
|
170.2
|
318.5
|
216.1
|
186.8
|
Free Cash Flow
1 |
1,042
|
2,446
|
7,110
|
11,270
|
457.5
|
3,164
|
FCF margin
|
0.39%
|
0.92%
|
2.63%
|
3.96%
|
0.16%
|
1.12%
|
FCF Conversion (EBITDA)
|
10.9%
|
27.52%
|
69.84%
|
75.33%
|
3.79%
|
29.02%
|
FCF Conversion (Net income)
|
26.92%
|
121.33%
|
186.03%
|
158.53%
|
9.47%
|
75.75%
|
Dividend per Share
2 |
45.00
|
45.00
|
45.00
|
45.00
|
50.00
|
50.00
|
Announcement Date
|
6/13/18
|
6/12/19
|
6/12/20
|
6/11/21
|
6/15/22
|
6/15/23
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
136,478
|
148,549
|
144,384
|
67,114
|
68,834
|
142,559
|
69,915
|
70,564
|
145,934
|
69,896
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
2,602
|
6,541
|
4,458
|
1,800
|
1,567
|
4,030
|
1,749
|
1,754
|
4,392
|
1,681
|
Operating Margin
|
1.91%
|
4.4%
|
3.09%
|
2.68%
|
2.28%
|
2.83%
|
2.5%
|
2.49%
|
3.01%
|
2.41%
|
Earnings before Tax (EBT)
1 |
3,076
|
6,831
|
4,909
|
2,040
|
1,785
|
4,226
|
1,960
|
1,971
|
4,550
|
1,925
|
Net income
1 |
2,020
|
4,611
|
3,256
|
1,378
|
1,178
|
2,811
|
1,296
|
1,313
|
3,047
|
1,259
|
Net margin
|
1.48%
|
3.1%
|
2.26%
|
2.05%
|
1.71%
|
1.97%
|
1.85%
|
1.86%
|
2.09%
|
1.8%
|
EPS
2 |
89.49
|
206.8
|
145.9
|
61.77
|
52.77
|
125.9
|
57.99
|
58.82
|
136.5
|
56.35
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/25/19
|
10/23/20
|
10/26/21
|
1/27/22
|
7/28/22
|
10/26/22
|
1/26/23
|
7/26/23
|
10/26/23
|
1/25/24
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
6,513
|
2,696
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
3,687
|
14,825
|
16,040
|
18,901
|
Leverage (Debt/EBITDA)
|
0.6813
x
|
0.3033
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1,042
|
2,446
|
7,110
|
11,270
|
458
|
3,164
|
ROE (net income / shareholders' equity)
|
4.28%
|
2.18%
|
4.08%
|
7.27%
|
4.7%
|
3.93%
|
ROA (Net income/ Total Assets)
|
1.52%
|
1.28%
|
1.88%
|
3.43%
|
2.48%
|
2.12%
|
Assets
1 |
255,363
|
157,821
|
202,899
|
207,302
|
195,010
|
196,954
|
Book Value Per Share
2 |
4,029
|
4,073
|
4,247
|
4,521
|
4,688
|
4,823
|
Cash Flow per Share
2 |
1,137
|
1,246
|
1,485
|
1,848
|
1,745
|
1,722
|
Capex
1 |
5,855
|
2,615
|
3,437
|
2,809
|
3,973
|
5,252
|
Capex / Sales
|
2.18%
|
0.99%
|
1.27%
|
0.99%
|
1.42%
|
1.86%
|
Announcement Date
|
6/13/18
|
6/12/19
|
6/12/20
|
6/11/21
|
6/15/22
|
6/15/23
|
|
1st Jan change
|
Capi.
|
---|
| +5.43% | 405M | | -22.54% | 3.27B | | -16.11% | 2.89B | | -30.41% | 2.81B | | +5.96% | 2.78B | | +7.93% | 2.68B | | -4.46% | 1.87B | | +10.93% | 1.4B | | -22.75% | 944M | | -0.53% | 419M |
Retail - Drugs with Grocery
|